Diagnostic and Therapeutic Approaches to Hepatocellular Carcinoma: Understanding the Barcelona Clínic Liver Cancer Protocol.
Each year, hepatocellular carcinoma is diagnosed in more than half a million people worldwide and it is the fifth most common cancer in men and the seventh most common cancer in women. This article reviews the Barcelona-Clínic Liver Cancer protocol for the diagnosis, staging, and treatment of this disease, and four cases are presented for the discussion of the therapeutic approach. Understanding the diagnostic and therapeutic approaches to this disease is essential, especially if we keep in mind the quintessential basics of prevention and early detection.
Professor, Faculty of Medicine, Universidade de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Master's in Hepatology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Jonathan
J
Soldera
Professor, Faculty of Medicine, Universidade de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Doctorate in Clinical Gastroenterology, Universidade de São Paulo, São Paulo, Brazil.
Silvana Sartori
SS
Balbinot
Professor, Faculty of Medicine, Universidade de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Doctorate in Clinical Gastroenterology, Universidade de São Paulo, São Paulo, Brazil.
Raul Angelo
RA
Balbinot
Resident Physician, Department of Gastroenterology, Hepatology and Digestive Endoscopy, Hospital Geral de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Internal Medicine, Hospital Geral de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.
Andreza Gautério
AG
Cavalcanti
hepatocellular carcinoma; liver cirrhosis; neoplasm staging